Termeer Foundation announces its Class of 2025 Termeer Fellows Incoming class reflects an increasing global footprint and engagement in multiple biotech ecosystems Today the Termeer Foundation announced its largest class of Termeer Fellows to date, with 17 first-time...

Join Hans Schikan, Co-Founder and Vice Chairman of Pharvaris and Termeer Foundation mentor, as he hosts an engaging conversation about patient-centered innovation. Hans welcomes Koenraad Wiedhaup, CEO of Leyden Labs, a company dedicated to eradicating viral threats,...

Having a child with a rare or ultra-rare disease often means traveling a lonely, uncertain path. Doctors may be unfamiliar with the condition and unsure how to diagnose or treat it — presuming treatments exist, which typically they do not. And it is unlikely that...

Looking across the biopharmaceutical industry landscape, several noteworthy medical advances have occurred in the last year. According to a recent article in STAT, new drugs for schizophrenia, muscular dystrophy, and pulmonary hypertension are among the most...

As we close out 2024—a year marked by political, social, and industry challenges—this conversation explores how biotech leaders can prioritize renewal and resilience. Join Michèle Berg, Managing Director of Envisage Consulting and executive coach, content consultant...

Leadership is about putting people first, especially in biotech. But for first-time CEOs and other biotech executives, that vision can be challenging to achieve while also fulfilling the various other duties their jobs require. Indeed, these trailblazers are working...

Program to counter ‘isolation’ felt by entrepreneurs, encourage community and ideation CAMBRIDGE – July 16, 2024 – Today, MassBio and The Termeer Foundation announced the launch of “CEO & Founder Link,” a dedicated network for founders and CEOs of emerging life...